Mental Health in Aviation and Medication Transparency Act Enhances Support for Pilots and Air Traffic Controllers, Here is the Update

Published on November 23, 2025

The National Business Aviation Association (NBAA) has expressed strong support for the introduction of two significant Senate bills, the Mental Health in Aviation Act and the Aviation Medication Transparency Act. These pieces of legislation are aimed at improving mental health care and enhancing transparency around medication usage for pilots and air traffic controllers. The NBAA has welcomed the bills as critical steps towards enhancing safety, well-being and the efficiency of aviation professionals.

Both bills were introduced in the Senate by Senators Tammy Duckworth (D-IL) and John Hoeven (R-ND). Earlier this year, the Mental Health in Aviation Act was passed by the House of Representatives, while the Aviation Medication Transparency Act was introduced there as well. These bills are set to address the growing concerns surrounding mental health in aviation and ensure that those working in this vital sector have access to the support they need.

Mental Health in Aviation Act: Reducing Stigma and Enhancing Access to Care

The Mental Health in Aviation Act is a groundbreaking piece of legislation aimed at modernizing mental health regulations for pilots and air traffic controllers. The primary goal of the act is to encourage the early disclosure and treatment of mental health conditions. The bill would modernize the guidance surrounding mental health evaluations, making it easier for aviation professionals to seek help without the fear of repercussions.

Key provisions of the Mental Health in Aviation Act include an annual review of the Federal Aviation Administration’s (FAA) Special Issuance Medical Certification process. This process evaluates the medical qualifications of pilots and controllers and can sometimes act as a barrier for individuals seeking treatment for mental health conditions. The bill aims to address this by allocating $15 million annually (FY2026–FY2029) to the FAA’s Office of Aerospace Medicine. These funds would be used to expand and train additional medical examiners, including specialists, to improve the efficiency of the FAA’s medical certification process.

Additionally, the Mental Health in Aviation Act allocates $1.5 million annually to fund a public information campaign. The goal of the campaign is to reduce the stigma surrounding mental health care, making it easier for aviation professionals to seek help without fear of judgment or career repercussions. By fostering a supportive environment, the act aims to make it easier for pilots and controllers to get the care they need when dealing with mental health issues.

NBAA President and CEO, Ed Bolen, has shown strong support for the Mental Health in Aviation Act. He emphasized the importance of creating an environment where aviation professionals feel safe in seeking help for mental health concerns. According to Bolen, it is essential to foster a culture of understanding that helps pilots, air traffic controllers and other aviation professionals reach out for help when needed. NBAA has been a longtime advocate for mental health improvements within the aviation sector, having represented business aviation on the 2023 Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee (ARC), which made similar recommendations to the FAA.

Aviation Medication Transparency Act: Ensuring Safe Medication Use for Aviation Professionals

In conjunction with the Mental Health in Aviation Act, the Aviation Medication Transparency Act is another critical step towards enhancing the support available for pilots and air traffic controllers. This act is designed to make it easier for aviation professionals to access vital information regarding medications that are safe for use during their duties. Currently, this information is available to aviation medical examiners but is not readily accessible to pilots and controllers in an easy-to-understand format.

Under the Aviation Medication Transparency Act, the FAA will be required to create a comprehensive, user-friendly list of medications that are safe for pilots, air traffic controllers and trainees to use. This list will be developed in consultation with various stakeholders, including medical professionals, regulators and industry leaders. The FAA will be required to update the list annually, ensuring that the information remains accurate and relevant.

The act also mandates that the FAA specify any restrictions on medication usage, such as whether individuals need to limit or cease duties while taking certain medications. It will also provide clear guidelines on which medications are deemed “safe to prescribe” and which are classified as “Do Not Issue.” This will help aviation professionals and their doctors make informed decisions about which treatments to pursue without jeopardizing their certifications or safety.

Enhancing Safety and Supporting Health

The introduction of these bills marks a significant step in supporting the mental health and well-being of those working in the aviation industry. By addressing mental health concerns and medication transparency, these acts will not only help reduce stigma but also enhance safety by ensuring that aviation professionals have access to accurate and helpful information.

Bolen stated that the Aviation Medication Transparency Act will empower pilots and controllers with the knowledge they need to work closely with their doctors to find treatments that minimize any potential impact on their certifications. By establishing a clear and accessible mechanism for accessing critical information about medications, the act will help reduce the risks associated with improper medication use in aviation.

Both the Mental Health in Aviation Act and the Aviation Medication Transparency Act are seen as essential pieces of legislation that will improve the safety, well-being and efficiency of the aviation workforce. The NBAA strongly supports these acts and believes they will contribute to a healthier and more effective aviation industry. By focusing on mental health and medication transparency, these bills are a step forward in making aviation a safer and more supportive environment for all professionals involved.

Conclusion

The Mental Health in Aviation Act and the Aviation Medication Transparency Act represent essential progress in the ongoing efforts to improve the mental health and medication access for aviation professionals. These acts are a reflection of the growing recognition of mental health as a critical issue within the aviation sector and they are expected to provide much-needed support for pilots, air traffic controllers and other aviation workers. The NBAA’s strong backing of these bills underlines their importance in fostering a safer, more supportive environment for everyone in the aviation industry.